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This ProhormoneTheory was simultaneously proposed in 1967 by two independent groups
using two different approaches and two experimental models. Donald Steiner, in elegant
pulse-chase experiments, proposed the existence of proinsulin when he observed that
a human insulinoma was producing higher MW forms of immunoreactive insulin, subse-
quently transformed into insulin-like material (1). Simultaneously and independently, Michel
Chrétien, based on amino acid sequence homologies between three pituitary peptides,
β-lipotropic hormone (β-LPH), γ-LPH, and β-melanocyte-stimulating hormone (β-MSH), con-
cluded that active peptide hormones are derived from endoproteolytic cleavages of inactive
precursors, apparently at pairs of basic amino acids (2). One year later, Donald Chance con-
firmed that the cleavage sites in proinsulin were also made of paired basic amino acids
(3).This novel paradigm solved two major controversies on the biosynthesis of both insulin
and neuropeptides. This short review describes how.
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THE INSULIN SAGA
In the mid 1950s and early 1960s, many scientists wandered how
insulin was synthesized in the pancreatic β-cells. Fred Sanger had
established that insulin is made of two peptide chains linked
by disulfide bridges (4). A prevailing view was that insulin was
biosynthesized as two separate peptide chains “zipped” post-
transcriptionally by interchain disulfide bridges. Preceding that
period, Oliver Smithies, as mentioned in his 2007 Nobel Lecture,
was looking for a precursor to insulin “which I never found” (5).
Many groups in the US, Canada, China, and Germany, using sepa-
rate insulin A and B chains,had tried to reconstitute insulin in vitro,
with minimal yield (6). In the mid-1960s, some in vitro studies of
pancreatic islet tissue had led to the conclusion that the two insulin
chains were biosynthesized as separate entities. The controversy
was definitely solved, when the amino acid sequence of proinsulin
unequivocally proved that insulin is made as a single polypep-
tide, subsequently modified to its active form by endoproteolysis
at pairs of basic residues (3).
THE NEUROPEPTIDE SAGA
The β-LPH/γ-LPH/β-MSH model of biosynthesis, initially pro-
posed in 1967 for pituitary peptides, contained elements that
would solved the upcoming controversy on neuropeptide biosyn-
thesis. In 1969, the field of neuroendocrinology underwent a
revolution when Roger Guillemin published the astonishing dis-
covery that thyrotropin releasing factor (TRF) was a tripeptide
(7). It was suggested that this tripeptide, like glutathione, was pro-
duced by a soluble non-ribosomal enzymatic mechanism and the
existence of a TRH synthetase was seriously considered.
The first indication that β-LPH could be a neuropeptide pre-
cursor came when Hughes and Kosterlitz published the amino
acid sequence of met-enkephalin and noted that it corresponded
to residues 61–65 of β-LPH (8). Shortly thereafter, many groups
revealed that the main opioid secretory product was the frag-
ment 61–91 of β-LPH, now universally known as β-endorphin,
a strong indication that β-LPH (1–91) was its most plausible
precursor candidate. Definite proof that β-LPH is the precursor
of β-endorphin came about when it was unequivocally demon-
strated that β-endorphin is produced by endoproteolytic cleavage
of β-LPH at pair basic residues 59–60 (9).
Coincidently, it was realized that β-LPH itself is part of a larger
precursor containing ACTH. The existence of this precursor was
confirmed with the cloning of its cDNA; in it, the sequences of its
active end products (β-endorphin, MSHs, and ACTH) are flanked
by the canonical pairs of basic residues (10). The precursor, now
named proopiomelanocortin (POMC) (11), has become the gold
standard of endocrine and neuroendocrine precursors. Soon after,
the cloning of cDNAs for the other neuropeptides confirmed that
all of them were produced through a similar mechanism (12).
The non-ribosomal enzymatic concept of TRH production thus
became obsolete. The endoproteolysis of polyproteins like Pro-
TRF and POMC (Figure 1) greatly amplifies the multiple active
end products of large precursor molecules (13).
During the following decades, post-translational endoprote-
olytic activation became applicable to numerous other polypro-
teins, including precursors to neurotrophins, growth factors, tran-
scription factors, receptors, extracellular matrix proteins, bacterial
toxins, viral glycoproteins, etc. It is now recognized as a funda-
mental cellular process, affecting many biological functions and
opened a new chapter in biology (13, 14).
The 1967 Prohormone Theory and its biological ramifica-
tions implied the existence of endoproteolytic enzymes dedicated
to the process (15). These were discovered 23 years later (16,
17). Collectively, they are called proprotein convertases (PCs)
or proproteins convertases subtilisin/kexin type (PCSKs). They
are calcium-dependent serine endoproteases, structurally related
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FIGURE 1 | Diagrammatic representations of prePOMC and preproTRH. The diagrams are based on rat sequences. The additional functional peptides of
proTRH have been reviewed by Nillni and Sevarino (21). Single and paired basic residues (K/R) flanking the functional peptides are shown. (sp: signal peptide).
to bacterial Subtilisin and to yeast Kexin (13, 18, 19). The first
two, PC1/3-PC2 are considered the prototypical convertases for
prohormones and proneuropeptides.
CONCLUSION
In solving two major controversies concerning the biosynthetic
pathways of insulin and neuropeptides, the 1967 prohormone the-
ory has become a tenet of the peptidergic systems in endocrinology
and neuroendocrinology. This is one of many other examples in
biology whereby incompatible hypotheses are clarified by one type
of results. One of the most famous is certainly the 1943 fluctua-
tion test of Salvador Luria and Max Delbruck (20). Although less
spectacular than the genetics of bacterial resistance, the prohor-
mone concept ended two scientific debates and led to new horizons
which surpassed all the most elaborate expectations.
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